IDT Australia (ASX:IDT) Insider Mark Simari Acquires 501,936 Shares

IDT Australia Limited (ASX:IDT) insider Mark Simari acquired 501,936 shares of the company’s stock in a transaction that occurred on Wednesday, February 18th. The stock was acquired at an average cost of A$0.05 per share, for a total transaction of A$24,092.93.

IDT Australia Price Performance

The firm has a market capitalization of $48.61 million, a P/E ratio of -7.47 and a beta of 1.22. The company has a quick ratio of 4.15, a current ratio of 1.34 and a debt-to-equity ratio of 19.06.

About IDT Australia

IDT Australia Limited engages in the research, development, manufacture, and sale of active pharmaceutical ingredients (APIs) and finished dose form products in Australia and internationally. It offers analytical method development, stability chambers, chemistry and microbiology quality control laboratory, and quality assurance services. The company also provides project management, chemical, analytical chemistry, pharmacy, clinical packaging, and regulatory affairs, as well as pharmaceutical development services in various dosage forms.